CIK: 0001388551 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value ($000): $91,477 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MOLECULAR TEMPLATES INC | 2,107,991 | $28,015 | 30.6% | $8.09 | — | COM | 608550109 |
| — | KALA PHARMACEUTICALS INC | 1,836,313 | $16,141 | 17.6% | $6.04 | — | COM | 483119103 |
| — | SATSUMA PHARMACEUTICALS INC | 606,320 | $13,048 | 14.3% | $15.01 | — | COM | 80405P107 |
| — | STRONGBRIDGE BIOPHARMA PLC | 6,612,065 | $12,497 | 13.7% | $2.92 | — | SHS USD | G85347105 |
| — | SIERRA ONCOLOGY INC | 643,959 | $6,324 | 6.9% | $9.82 | — | COM NEW | 82640U404 |
| — | SCYNEXIS INC | 7,936,111 | $6,198 | 6.8% | $1.12 | — | COM | 811292101 |
| — | SUNESIS PHARMACEUTICALS INC | 8,134,926 | $3,375 | 3.7% | $0.61 | — | COM PAR | 867328700 |
| — | GARRISON CAP INC | 1,164,061 | $1,979 | 2.2% | $8.25 | — | COM | 366554103 |
| — | MEI PHARMA INC | 885,560 | $1,426 | 1.6% | $3.83 | — | COM NEW | 55279B202 |
| — | CTI BIOPHARMA CORP | 616,695 | $567 | 0.6% | $1.19 | — | COM NEW | 12648L601 |
| — | EIGER BIOPHARMACEUTICALS INC | 81,617 | $555 | 0.6% | $10.26 | — | COM | 28249U105 |
| — | FS KKR CAPITAL CORP | 170,332 | $511 | 0.6% | $4.75 | — | COM | 302635107 |
| CCAP | CRESCENT CAP BDC INC | 34,405 | $332 | 0.4% | $6.95 | 0.0% | COM | 225655109 |
| KURA | KURA ONCOLOGY INC | 22,302 | $222 | 0.2% | $17.68 | -35.3% | COM | 50127T109 |
| — | CALUMET SPECIALTY PRODS PTNR | 131,204 | $138 | 0.2% | $3.65 | — | UT LTD PARTNER | 131476103 |
| — | ADDEX THERAPEUTICS LTD | 17,418 | $115 | 0.1% | $6.60 | — | SPONSORED ADS | 00654J107 |
| — | GLYCOMIMETICS INC | 15,103 | $34 | 0.0% | $4.33 | — | COM | 38000Q102 |